Skip to main content

The MASALA Study Unpacks South Asians’ Heart and Metabolic Disease Risk

A long-running study of South Asians investigates why they are more prone to diabetes and heart disease, highlighting the need for alternate screening methods.

Written bySneha Khedkar
| 3 min read
Spices on a table arranged in the shape of a heart, signifying the MASALA study which investigates South Asian population’s risk factors for cardiometabolic disease.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

As a person of Indian origin, Alka Kanaya saw diabetes and heart disease wreak havoc in her family. As a general internist and physician scientist at the University of California, San Francisco (UCSF), Kanaya witnessed a similar trend. “It's very common to see a young South Asian man present with a heart attack in their thirties and forties, where you don't see that in other groups,” said Kanaya.

Four women, part of the MASALA study team, pose in front of photo frames carrying pictures of zebras.

Scientists from UCSF investigate South Asian populations as part of the MASALA study.

Alka Kanaya

While South Asians make up about a quarter of the world’s population, they bear nearly 60 percent of the global burden of heart disease.1 They are also more prone to diabetes compared to other ethnic groups.2 Some hypotheses attribute these outcomes to insulin resistance, wherein cells do not respond to insulin, and central adiposity, or fat accumulation around the midsection.

However, Kanaya was not entirely satisfied. “That didn't seem to really answer the big question for me about why and how do you prevent it,” she said.

To fill this gap, Kanaya launched a longitudinal study called the Mediators of Atherosclerosis in South Asians Living in America (MASALA). The study, whose acronym is a Hindi word for spices, started in 2006 with 150 participants and has now expanded to about 2,300. By examining various health parameters among South Asians, Kanaya and her team pinpointed factors that potentially contribute to heightened diabetes and heart disease risk in this ethnic group. Today, MASALA is the longest-running study tracking South Asian people’s health over time, contributing to a better understanding of not just risk factors but also screening guidelines.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Capturing Differences Among South Asians

A few people posing for a photograph.

Kanaya eventually expanded her study to include scientists from Northwestern University.

Alka Kanaya

For MASALA, Kanaya drew inspiration from the Multi-Ethnic Study of Atherosclerosis (MESA), a longitudinal study examining early atherosclerosis in White, African American, Hispanic, and Chinese populations. Hoping to get a fuller picture of the forces pushing disease in diverse populations, scientists from both studies joined forces.

“Having that MESA comparison really shines a light at how different South Asians are,” said Kanaya. For instance, comparing the body composition among MESA and MASALA participants revealed that the latter had more liver and visceral fat, which are strongly linked with heart disease and diabetes risk.3 They also had lower lean mass, another risk factor for diabetes, compared to other populations.

One of the studies under MASALA also revealed that insulin resistance is not as prevalent as once thought: South Asians are more prone to a less common variant of type 2 diabetes, wherein pancreatic beta cells do not produce enough insulin.4 While people who are insulin resistant may respond to certain lifestyle modifications, “those who have [impaired] pancreatic beta cell function are less likely to respond,” said Kanaya, highlighting that there is no one-size-fits-all treatment approach.

Kanaya and her team also argued that since South Asians can develop diabetes at a lower body mass index (BMI) level compared to other populations, the BMI cutoff point for diagnostic tests for them should be lower.5 This underscores the importance of having different screening guidelines for this population.

Some people pose for a photograph.

Expanding the study to New York University gave Kanaya the opportunity to enroll more people of Bangladeshi and Pakistani origins.

Alka Kanaya

Aside from observing differences between South Asians and others, Kanaya and her team also uncovered an additional layer of variation within the South Asian community. Two centers at Northwestern University and New York University recently recruited Bangladeshi and Pakistani immigrants to the MASALA study. According to Kanaya, Pakistanis have a higher burden of diabetes compared to Indians, and Bangladeshis have an even higher rate of the disease, highlighting the pitfalls of categorizing diverse people under one umbrella population.

Serving the Community at the Heart of MASALA

Kanaya hopes that insights from the MASALA study will aid those she set out to help back in 2006. “It’s important to ground what we do in the communities that we intend to serve,” said Kanaya.

Kanaya and her team educate South Asian people about the novel findings from their studies, “so that what we learn is going back into the communities and hopefully helping raise awareness and prevent disease in those communities.”

Over time, Kanaya hopes to expand the study cohort to obtain even deeper insights into disease risk among South Asians. Until then, she wants to continue doing what they have been doing for the last two decades. “We [want to] continue to raise awareness and learn as much as we can from even this tiny little cohort,” said Kanaya.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Sneha Khedkar

    Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master’s degree in biochemistry, after which she studied the molecular mechanisms of skin stem cell migration during wound healing as a research fellow at the Institute for Stem Cell Science and Regenerative Medicine in Bangalore, India. She has previously written for Scientific American, New Scientist, and Knowable Magazine, among others.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays